Tapewire

NYSE · USD

MPT

MEDICAL PROPERTIES TRUST INC

Export transactions ↓
Tapewire entity
4372
SEC CIK
0001287865
Parsed reports
335

Last 12 months

Inside the activity.

1 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202610
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 04, 2020 Filed Nov 5, 2020 22:06 UTC SaleCommon stock, par value $0.001 6,300 $19.11 $120,393.00
Disclosure

SEC source: 0001287865-20-000032 · primary_doc.xml · nonDerivative · entry 1

Stewart Michael G · CIK 0001331453 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 213,756

Read SEC document
October 08, 2020 Filed Feb 13, 2023 19:01 UTC OtherCommon stock, par value $0.001 46 $18.40 $846.40
Disclosure

SEC source: 0001287865-23-000016 · primary_doc.xml · nonDerivative · entry 4

Pitman Elizabeth N · CIK 0001732148 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,876

F1 · shares: Pertains to de minimis dividend reinvestment transactions.

Read SEC document
September 14, 2020 Filed Feb 12, 2021 22:32 UTC
HAMNER R STEVENDirector · Executive Vice President & CFO
GiftCommon stock, par value $0.001 27,200 $0.00 $0.00
Disclosure

SEC source: 0001287865-21-000011 · primary_doc.xml · nonDerivative · entry 3

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,042,688

Read SEC document
August 04, 2020 Filed Aug 4, 2020 21:40 UTC
Hanna James KevinVP, Controller & CAO
SaleCommon stock, par value $0.001 17,500 $20.02 $350,350.00
Disclosure

SEC source: 0001287865-20-000031 · primary_doc.xml · nonDerivative · entry 1

Hanna James Kevin · CIK 0001665881 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,156

F1 · price: This transaction was executed in multiple trades at prices ranging from $20.02 to $20.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 16, 2020 Filed Feb 13, 2023 19:01 UTC OtherCommon stock, par value $0.001 46 $18.23 $838.58
Disclosure

SEC source: 0001287865-23-000016 · primary_doc.xml · nonDerivative · entry 3

Pitman Elizabeth N · CIK 0001732148 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,830

F1 · shares: Pertains to de minimis dividend reinvestment transactions.

Read SEC document
July 14, 2020 Filed Feb 12, 2021 22:40 UTC
Aldag Edward K JRDirector · Chairman, President & CEO
GiftCommon stock, par value $0.001 91,730 $0.00 $0.00
Disclosure

SEC source: 0001287865-21-000012 · primary_doc.xml · nonDerivative · entry 1

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,961,167

Read SEC document
July 08, 2020 Filed Jul 8, 2020 21:08 UTC
Aldag Edward K JRDirector · Chairman, President & CEO
SaleCommon stock, par value $0.001 244,406 $18.43 $4,504,402.58
Disclosure

SEC source: 0001287865-20-000030 · primary_doc.xml · nonDerivative · entry 2

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,984,778

Read SEC document
July 07, 2020 Filed Jul 8, 2020 21:08 UTC
Aldag Edward K JRDirector · Chairman, President & CEO
SaleCommon stock, par value $0.001 156,569 $18.60 $2,912,183.40
Disclosure

SEC source: 0001287865-20-000030 · primary_doc.xml · nonDerivative · entry 1

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,229,184

Read SEC document
July 06, 2020 Filed Jul 6, 2020 20:26 UTC
McLean Emmett EExecutive Vice President & COO
SaleCommon stock, par value $0.001 200,000 $18.99 $3,798,000.00
Disclosure

SEC source: 0001287865-20-000029 · primary_doc.xml · nonDerivative · entry 1

McLean Emmett E · CIK 0001331446 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,280,178

Read SEC document
July 02, 2020 Filed Jul 2, 2020 21:09 UTC
HAMNER R STEVENDirector · Executive Vice President & CFO
SaleCommon stock, par value $0.001 220,000 $19.12 $4,206,400.00
Disclosure

SEC source: 0001287865-20-000028 · primary_doc.xml · nonDerivative · entry 1

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,605,829

Read SEC document
July 01, 2020 Filed Jul 1, 2020 22:39 UTC SaleCommon stock, par value $0.001 5,000 $19.09 $95,450.00
Disclosure

SEC source: 0001287865-20-000027 · primary_doc.xml · nonDerivative · entry 1

Stewart Michael G · CIK 0001331453 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,056

Read SEC document
April 09, 2020 Filed Feb 13, 2023 19:01 UTC OtherCommon stock, par value $0.001 44 $18.74 $824.56
Disclosure

SEC source: 0001287865-23-000016 · primary_doc.xml · nonDerivative · entry 2

Pitman Elizabeth N · CIK 0001732148 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,784

F1 · shares: Pertains to de minimis dividend reinvestment transactions.

Read SEC document
April 02, 2020 Filed Apr 2, 2020 21:15 UTC
Hanna James KevinVP, Controller & CAO
GrantCommon stock, par value $0.001 5,500 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000026 · primary_doc.xml · nonDerivative · entry 2

Hanna James Kevin · CIK 0001665881 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,656

F2 · shares: Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's per share funds from operations, EBITDA, and acquisitions, as defined and set by our compensation committee, over the period from January 1, 2020 through December 31, 2022, with the opportunity to earn up to one third of the award for 2020 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of specific performance thresholds.

Read SEC document
April 02, 2020 Filed Apr 2, 2020 21:15 UTC
Hanna James KevinVP, Controller & CAO
GrantCommon stock, par value $0.001 11,000 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000026 · primary_doc.xml · nonDerivative · entry 1

Hanna James Kevin · CIK 0001665881 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,156

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2020.

Read SEC document
March 27, 2020 Filed Mar 27, 2020 16:19 UTC GrantCommon stock, par value $0.001 5,241 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000020 · primary_doc.xml · nonDerivative · entry 1

DAWSON G STEVEN · CIK 0001020944 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,043

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2020.

Read SEC document
March 27, 2020 Filed Mar 27, 2020 17:12 UTC GrantCommon stock, par value $0.001 5,241 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000025 · primary_doc.xml · nonDerivative · entry 1

Mozingo Caterina Ardon · CIK 0001804387 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,241

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2020.

Read SEC document
March 27, 2020 Filed Mar 27, 2020 16:29 UTC GrantCommon stock, par value $0.001 5,241 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000021 · primary_doc.xml · nonDerivative · entry 1

Pitman Elizabeth N · CIK 0001732148 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,222

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2020.

Read SEC document
March 27, 2020 Filed Mar 27, 2020 20:59 UTC GrantCommon stock, par value $0.001 5,241 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000024 · primary_doc.xml · nonDerivative · entry 1

THOMPSON C REYNOLDS III · CIK 0001188038 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,803

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2020.

Read SEC document
March 27, 2020 Filed Mar 27, 2020 20:48 UTC GrantCommon stock, par value $0.001 5,241 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000023 · primary_doc.xml · nonDerivative · entry 1

Stewart Michael G · CIK 0001331453 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,056

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2020.

Read SEC document
March 27, 2020 Filed Mar 27, 2020 20:38 UTC GrantCommon stock, par value $0.001 5,241 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000022 · primary_doc.xml · nonDerivative · entry 1

SPARKS DANIEL PAUL · CIK 0001619358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,319

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2020.

Read SEC document
March 10, 2020 Filed Feb 12, 2021 22:32 UTC
HAMNER R STEVENDirector · Executive Vice President & CFO
GiftCommon stock, par value $0.001 50,000 $0.00 $0.00
Disclosure

SEC source: 0001287865-21-000011 · primary_doc.xml · nonDerivative · entry 2

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,069,888

Read SEC document
March 03, 2020 Filed Feb 12, 2021 22:32 UTC
HAMNER R STEVENDirector · Executive Vice President & CFO
GiftCommon stock, par value $0.001 20,000 $0.00 $0.00
Disclosure

SEC source: 0001287865-21-000011 · primary_doc.xml · nonDerivative · entry 1

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,119,888

Read SEC document
February 27, 2020 Filed Feb 28, 2020 22:45 UTC
HAMNER R STEVENDirector · Executive Vice President & CFO
GrantCommon stock, par value $0.001 172,927 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000018 · primary_doc.xml · nonDerivative · entry 2

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,825,829

F2 · shares: Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's per share funds from operations, EBITDA, and acquisitions, as defined and set by our compensation committee, over the period from January 1, 2020 through December 31, 2022, with the opportunity to earn up to one third of the award for 2020 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of specific performance thresholds.

Read SEC document
February 27, 2020 Filed Feb 28, 2020 22:45 UTC
HAMNER R STEVENDirector · Executive Vice President & CFO
GrantCommon stock, par value $0.001 89,084 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000018 · primary_doc.xml · nonDerivative · entry 1

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,652,902

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2020.

Read SEC document
February 27, 2020 Filed Feb 28, 2020 22:57 UTC
Aldag Edward K JRDirector · Chairman, President & CEO
GrantCommon stock, par value $0.001 345,854 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000019 · primary_doc.xml · nonDerivative · entry 2

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,385,753

F2 · shares: Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's per share funds from operations, EBITDA, and acquisitions, as defined and set by our compensation committee, over the period from January 1, 2020 through December 31, 2022, with the opportunity to earn up to one third of the award for 2020 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of specific performance thresholds.

Read SEC document
February 27, 2020 Filed Feb 28, 2020 22:57 UTC
Aldag Edward K JRDirector · Chairman, President & CEO
GrantCommon stock, par value $0.001 178,167 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000019 · primary_doc.xml · nonDerivative · entry 1

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,039,899

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2020.

Read SEC document
February 27, 2020 Filed Feb 28, 2020 22:28 UTC
McLean Emmett EExecutive Vice President & COO
GrantCommon stock, par value $0.001 129,958 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000017 · primary_doc.xml · nonDerivative · entry 2

McLean Emmett E · CIK 0001331446 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,480,178

F2 · shares: Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's per share funds from operations, EBITDA, and acquisitions, as defined and set by our compensation committee, over the period from January 1, 2020 through December 31, 2022, with the opportunity to earn up to one third of the award for 2020 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of specific performance thresholds.

Read SEC document
February 27, 2020 Filed Feb 28, 2020 22:28 UTC
McLean Emmett EExecutive Vice President & COO
GrantCommon stock, par value $0.001 64,979 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000017 · primary_doc.xml · nonDerivative · entry 1

McLean Emmett E · CIK 0001331446 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,350,220

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2020.

Read SEC document
February 10, 2020 Filed Feb 12, 2021 22:50 UTC GiftCommon stock, par value $0.001 1,905 $0.00 $0.00
Disclosure

SEC source: 0001287865-21-000013 · primary_doc.xml · nonDerivative · entry 1

THOMPSON C REYNOLDS III · CIK 0001188038 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,826

Read SEC document
February 07, 2020 Filed Feb 11, 2020 23:06 UTC
HAMNER R STEVENDirector · Executive Vice President & CFO
ConversionRestricted common stock units · Derivative 53,037 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000007 · primary_doc.xml · derivative · entry 4

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,905

Underlying: Common stock, par value $0.001 · 53,037 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares earned under the 2018 performance award equal to approximately one third of the target number of shares granted.

F4 · derivative.exercise_date: The shares vested on January 1, 2020.

F4 · derivative.expiration_date: The shares vested on January 1, 2020.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 23:06 UTC
HAMNER R STEVENDirector · Executive Vice President & CFO
GrantCommon stock, par value $0.001 194,712 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000007 · primary_doc.xml · nonDerivative · entry 3

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,636,918

F3 · shares: Represents shares earned under the 2019 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement along with shares earned pursuant to the modifier provisions in the award, which allowed for more shares to be earned based on how the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. The shares vested on January 1, 2020.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 23:06 UTC
HAMNER R STEVENDirector · Executive Vice President & CFO
GrantCommon stock, par value $0.001 79,557 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000007 · primary_doc.xml · nonDerivative · entry 2

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,442,206

F2 · shares: Represents additional shares earned under the 2018 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement along with shares earned pursuant to the modifier provisions in the award, which allowed for more shares to be earned based on how the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 23:06 UTC
HAMNER R STEVENDirector · Executive Vice President & CFO
ConversionCommon stock, par value $0.001 53,037 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000007 · primary_doc.xml · nonDerivative · entry 1

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,362,649

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares earned under the 2018 performance award equal to approximately one third of the target number of shares granted.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 22:11 UTC
Hanna James KevinVP, Controller & CAO
ConversionRestricted common stock units · Derivative 2,085 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000005 · primary_doc.xml · derivative · entry 4

Hanna James Kevin · CIK 0001665881 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,192

Underlying: Common stock, par value $0.001 · 2,085 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares earned under the 2018 performance award equal to approximately one third of the target number of shares granted.

F4 · derivative.exercise_date: The shares vested on January 1, 2020.

F4 · derivative.expiration_date: The shares vested on January 1, 2020.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 22:11 UTC
Hanna James KevinVP, Controller & CAO
GrantCommon stock, par value $0.001 1,668 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000005 · primary_doc.xml · nonDerivative · entry 3

Hanna James Kevin · CIK 0001665881 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,156

F3 · shares: Represents additional shares earned under the 2019 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement. The shares vested on January 1, 2020.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 22:11 UTC
Hanna James KevinVP, Controller & CAO
GrantCommon stock, par value $0.001 2,085 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000005 · primary_doc.xml · nonDerivative · entry 2

Hanna James Kevin · CIK 0001665881 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,488

F2 · shares: Represents additional shares earned under the 2018 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 22:11 UTC
Hanna James KevinVP, Controller & CAO
ConversionCommon stock, par value $0.001 2,085 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000005 · primary_doc.xml · nonDerivative · entry 1

Hanna James Kevin · CIK 0001665881 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,403

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares earned under the 2018 performance award equal to approximately one third of the target number of shares granted.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 22:41 UTC
McLean Emmett EExecutive Vice President & COO
ConversionRestricted common stock units · Derivative 47,733 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000006 · primary_doc.xml · derivative · entry 4

McLean Emmett E · CIK 0001331446 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,315

Underlying: Common stock, par value $0.001 · 47,733 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares earned under the 2018 performance award equal to approximately one third of the target number of shares granted.

F4 · derivative.exercise_date: The shares vested on January 1, 2020.

F4 · derivative.expiration_date: The shares vested on January 1, 2020.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 22:41 UTC
McLean Emmett EExecutive Vice President & COO
GrantCommon stock, par value $0.001 175,240 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000006 · primary_doc.xml · nonDerivative · entry 3

McLean Emmett E · CIK 0001331446 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,297,991

F3 · shares: Represents shares earned under the 2019 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement along with shares earned pursuant to the modifier provisions in the award, which allowed for more shares to be earned based on how the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. The shares vested on January 1, 2020.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 22:41 UTC
McLean Emmett EExecutive Vice President & COO
GrantCommon stock, par value $0.001 71,603 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000006 · primary_doc.xml · nonDerivative · entry 2

McLean Emmett E · CIK 0001331446 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,122,751

F2 · shares: Represents additional shares earned under the 2018 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement along with shares earned pursuant to the modifier provisions in the award, which allowed for more shares to be earned based on how the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 22:41 UTC
McLean Emmett EExecutive Vice President & COO
ConversionCommon stock, par value $0.001 47,733 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000006 · primary_doc.xml · nonDerivative · entry 1

McLean Emmett E · CIK 0001331446 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,051,148

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares earned under the 2018 performance award equal to approximately one third of the target number of shares granted.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 23:25 UTC
Aldag Edward K JRDirector · Chairman, President & CEO
ConversionRestricted common stock units · Derivative 106,073 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000008 · primary_doc.xml · derivative · entry 4

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,814

Underlying: Common stock, par value $0.001 · 106,073 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares earned under the 2018 performance award equal to approximately one third of the target number of shares granted.

F4 · derivative.exercise_date: The shares vested on January 1, 2020.

F4 · derivative.expiration_date: The shares vested on January 1, 2020.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 23:25 UTC
Aldag Edward K JRDirector · Chairman, President & CEO
GrantCommon stock, par value $0.001 389,416 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000008 · primary_doc.xml · nonDerivative · entry 3

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,861,732

F3 · shares: Represents shares earned under the 2019 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement along with shares earned pursuant to the modifier provisions in the award, which allowed for more shares to be earned based on how the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. The shares vested on January 1, 2020.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 23:25 UTC
Aldag Edward K JRDirector · Chairman, President & CEO
GrantCommon stock, par value $0.001 159,113 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000008 · primary_doc.xml · nonDerivative · entry 2

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,472,316

F2 · shares: Represents additional shares earned under the 2018 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement along with shares earned pursuant to the modifier provisions in the award, which allowed for more shares to be earned based on how the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 23:25 UTC
Aldag Edward K JRDirector · Chairman, President & CEO
ConversionCommon stock, par value $0.001 106,073 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000008 · primary_doc.xml · nonDerivative · entry 1

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,313,203

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares earned under the 2018 performance award equal to approximately one third of the target number of shares granted.

Read SEC document
January 09, 2020 Filed Feb 13, 2023 19:01 UTC OtherCommon stock, par value $0.001 38 $21.01 $798.38
Disclosure

SEC source: 0001287865-23-000016 · primary_doc.xml · nonDerivative · entry 1

Pitman Elizabeth N · CIK 0001732148 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,740

F1 · shares: Pertains to de minimis dividend reinvestment transactions.

Read SEC document
January 08, 2020 Filed Jan 9, 2020 23:38 UTC
McLean Emmett EExecutive Vice President & COO
SaleCommon stock, par value $0.001 100,000 $20.84 $2,084,000.00
Disclosure

SEC source: 0001287865-20-000004 · primary_doc.xml · nonDerivative · entry 1

McLean Emmett E · CIK 0001331446 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,003,415

F1 · price: This transaction was executed in multiple trades at prices ranging from $20.80 to $20.88. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 31, 2019 Filed Jan 2, 2020 22:24 UTC
HAMNER R STEVENDirector · Executive Vice President & CFO
GrantCommon stock, par value $0.001 74,155 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000002 · primary_doc.xml · nonDerivative · entry 1

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,309,612

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2020.

Read SEC document
December 31, 2019 Filed Jan 2, 2020 22:45 UTC
McLean Emmett EExecutive Vice President & COO
GrantCommon stock, par value $0.001 37,078 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000003 · primary_doc.xml · nonDerivative · entry 1

McLean Emmett E · CIK 0001331446 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,103,415

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2020.

Read SEC document
December 31, 2019 Filed Jan 2, 2020 22:04 UTC
Aldag Edward K JRDirector · Chairman, President & CEO
GrantCommon stock, par value $0.001 148,310 $0.00 $0.00
Disclosure

SEC source: 0001287865-20-000001 · primary_doc.xml · nonDerivative · entry 1

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,207,130

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2020.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.